[HTML][HTML] Licensed liposomal vaccines and adjuvants in the antigen delivery system

Y Krasnopolsky, D Pylypenko - BioTechnologia, 2022 - ncbi.nlm.nih.gov
Liposomes (LSs) are promising nanoparticles with unique properties such as controlled
nanosize, large surface area, increased reactivity, and ability to undergo modification …

Development and characterization of gels and liposomes containing ovalbumin for nasal delivery

M Kaplan, F Tuğcu-Demiröz, İ Vural, N Çelebi - Journal of drug delivery …, 2018 - Elsevier
Nasal delivery is an emerging strategy to prevent both local and systemic diseases. The aim
of this study was to develop a promising and innovative therapeutic system for the nasal …

Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications

B Karunakaran, R Gupta, P Patel, S Salave, A Sharma… - Vaccines, 2023 - mdpi.com
Lipid-based vaccine delivery systems such as the conventional liposomes, virosomes,
bilosomes, vesosomes, pH-fusogenic liposomes, transferosomes, immuno-liposomes …

Liposomes for the delivery of lipopeptide vaccines

J Yang, A Azuar, I Toth, M Skwarczynski - Vaccine Design: Methods and …, 2022 - Springer
Liposomes, which are artificial phospholipid vesicles with a bilayer membrane structure,
have been developed and evaluated as a promising delivery system for vaccines. Here, we …

Advances in lipid-based subunit vaccine formulations

J Myschik, T Rades, S Hook - Current Immunology Reviews, 2009 - ingentaconnect.com
Advances in vaccine formulation have seen a trend towards the use of subunit antigens,
ideally incorporated into particulate carriers. These systems are usually in the nanometer …

Liposomal presentation of antigens for human vaccines

R Glück - Vaccine design: the subunit and adjuvant approach, 1995 - Springer
The increasing use of liposomes in biology and medicine has prompted a rigorous
characterization of both classical multilamellar vesicle and novel liposome preparations …

Nasal vaccine delivery

M Ramvikas, M Arumugam, SR Chakrabarti… - … and nanotechnology in …, 2017 - Elsevier
The mucosal surfaces represent the major site of entry of many pathogens, and major
challenges in vaccine development include safety and stability in a suitable dosage form …

Liposomes and ISCOMS

GFA Kersten, DJA Crommelin - Vaccine, 2003 - Elsevier
Liposomes and ISCOMs have a long history as vehicles for antigen delivery. Liposomes can
carry both membrane associated antigens as well as water soluble molecules. Their …

Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators

S Tandrup Schmidt, C Foged, K Smith Korsholm… - Pharmaceutics, 2016 - mdpi.com
The development of subunit vaccines has become very attractive in recent years due to their
superior safety profiles as compared to traditional vaccines based on live attenuated or …

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

P Nordly, HB Madsen, HM Nielsen… - Expert opinion on drug …, 2009 - Taylor & Francis
Vaccines seek to adopt pathogen-like characteristics but not true pathogen characteristics to
activate the immune system without causing life-threatening disease. Vaccine formulations …